Nexalin Technology, Inc. (NXL)
Last updated: 2026-10-21 00:00:40. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
Summary
Nexalin Technology, Inc. (NXL) operates in the ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS sector and is listed on NASDAQ. The stock is currently priced at $2.14, with a market capitalization of $2.46M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $2.10 to $50.70. This page covers its latest market performance, valuation, price trends and company information.
Key Market Data
$2.46M | |
$2.52 | |
$1,016.40 | |
$2.10 | |
$2.36 | |
241.96K | |
1.04M | |
-- | |
$50.70 | |
$2.10 | |
-- | |
-- |
Nexalin Technology, Inc. (NXL) Latest Closing Stock Price
Nexalin Technology, Inc. (NXL) last closed at $2.36 as of 2026-10-20 23:54:00, unchanged from the previous close of $2.36.
During the latest regular trading session, NXL traded between $2.10 and $1,016.40, with a volume of 241.96K shares. The closing price was near the lower end and near the lower end of its 52-week range.
Nexalin Technology, Inc. (NXL) 7-Day Stock Price Change
Over the past seven days, Nexalin Technology, Inc. (NXL) moved from $3.63 to $2.14, representing a decline of 41.18% ($1.50).
The stock traded between $2.10 and $3.95 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.
The average daily volume was 56.83 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
NXL 52-Week Price Position
Position in Range: 0.1%
NXL is currently trading at $2.14, placing it 0.1% of the way from its 52-week low of $2.10 to its 52-week high of $50.70. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
What is Nexalin Technology, Inc. (NXL)?
Nexalin Technology Inc designs and develops neurostimulation products and bioelectronic medical technology to treat anxiety and insomnia without drugs or psychotherapy. The Company has developed the Generation 1 (Gen 1) medical device, a cranial electrotherapy stimulation (CES) device classified by the U.S. Food and Drug Administration (FDA) as a Class II device. The Company operates as a single operating and reportable segment, focused on the design and development of innovative neurostimulation products. The Company focuses on treating mental health conditions without reliance on drugs or psychotherapy. Geographically, it generates sales in the USA and China, with China generating the maximum sales.
Nexalin Technology, Inc. Information
| Industry | ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS |
| Employees | 8 |
| Exchange | NASDAQ |
| Company Website |
How to Buy Nexalin Technology, Inc. (NXL) Stock on MEXC
Eligible investors can buy real shares of Nexalin Technology, Inc. (NXL) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Frequently Asked Questions (FAQ)
1.What is Nexalin Technology, Inc. (NXL) stock price today?
2.Is NXL stock going up or down today?
3.What is NXL pre-market price?
4.What is NXL after-hours price?
5.Is NXL stock trading now?
6.Where does NXL sit relative to its 52-week high and low?
7.What sector is Nexalin Technology, Inc. in?
8.What is Nexalin Technology, Inc.'s market capitalization and where is it listed?
9.How is NXL valued in terms of P/E ratio and EPS?
10.Does Nexalin Technology, Inc. pay a dividend?
Explore More US Stocks
Search Stocks
NXL Stock Calculator
Estimate the value between NXL shares and USD.
NXL Shares to USD
1.00 NXL shares = 2.135 USD
Calculations are estimates based on the latest available price and are for reference only.


